Back to Search
SIRISHA CHADA, M.D.
M.D.
Family Medicine Physician
NPI: 1184061699IndividualAccepts Medicare
Specialties, Licenses & Credentials
Student in an Organized Health Care Education/Training Program
Student in an Organized Health Care Education/Training Program
Code: 390200000X
Family Medicine PhysicianPrimary
Family Medicine
Code: 207Q00000X
MD.35454(AL)
Education
OTHER
Class of 2012
Research & Publications (20)
Nerve growth factor signaling regulates motility and docking of axonal mitochondria.
PMID 15268858·Curr Biol·2004
7-preclinical
Mitochondrial movement and positioning in axons: the role of growth factor signaling.
PMID 12756280·J Exp Biol·2003
6-review
Adenoviral endoplasmic reticulum-targeted mda-7/interleukin-24 vector enhances human cancer cell killing.
PMID 18723497·Mol Cancer Ther·2008
7-preclinical
Phase I study of adenovirus p53 administered by bronchoalveolar lavage in patients with bronchioloalveolar cell lung carcinoma: ECOG 6597.
PMID 18757331·J Clin Oncol·2008
3-trial
Interleukin-24 overcomes temozolomide resistance and enhances cell death by down-regulation of O6-methylguanine-DNA methyltransferase in human melanoma cells.
PMID 19056673·Mol Cancer Ther·2008
8-other
MDA-7/IL-24, a novel tumor suppressor/cytokine is ubiquitinated and regulated by the ubiquitin-proteasome system, and inhibition of MDA-7/IL-24 degradation enhances the antitumor activity.
PMID 17828282·Cancer Gene Ther·2008
8-other
Development of Ad-mda7/IL-24-resistant lung cancer cell lines.
PMID 18059175·Cancer Biol Ther·2008
8-other
Killing of human melanoma cells induced by activation of class I interferon-regulated signaling pathways via MDA-7/IL-24.
PMID 18511292·Cytokine·2008
8-other
Enhancement of adenoviral MDA-7-mediated cell killing in human lung cancer cells by geldanamycin and its 17-allyl- amino-17-demethoxy analogue.
PMID 17024233·Cancer Gene Ther·2007
8-other
Inhibition of nuclear factor-kappaB augments antitumor activity of adenovirus-mediated melanoma differentiation-associated gene-7 against lung cancer cells via mitogen-activated protein kinase kinase kinase 1 activation.
PMID 17431123·Mol Cancer Ther·2007
7-preclinical
mda-7/IL-24, novel anticancer cytokine: focus on bystander antitumor, radiosensitization and antiangiogenic properties and overview of the phase I clinical experience (Review).
PMID 17912425·Int J Oncol·2007
6-review
mda-7 In combination with bevacizumab treatment produces a synergistic and complete inhibitory effect on lung tumor xenograft.
PMID 17235306·Mol Ther·2007
7-preclinical
MDA-7/IL-24 suppresses human ovarian carcinoma growth in vitro and in vivo.
PMID 17274815·Mol Cancer·2007
7-preclinical
Human interleukin 24 (MDA-7/IL-24) protein kills breast cancer cells via the IL-20 receptor and is antagonized by IL-10.
PMID 16710719·Cancer Immunol Immunother·2007
8-other
Apoptin studies illuminate intersection between lipidomics and tumor suppressors.
PMID 17164768·Mol Ther·2007
7-preclinical
Vitamin E succinate in combination with mda-7 results in enhanced human ovarian tumor cell killing through modulation of extrinsic and intrinsic apoptotic pathways.
PMID 17449172·Cancer Lett·2007
8-other
MDA-7/IL-24-based cancer gene therapy: translation from the laboratory to the clinic.
PMID 16475947·Curr Gene Ther·2006
6-review
Combination of p53 cancer vaccine with chemotherapy in patients with extensive stage small cell lung cancer.
PMID 16467102·Clin Cancer Res·2006
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 2217 DECATUR HWY, SUITE 101
GARDENDALE, AL 35071 - Phone
- (205) 418-1200
Quick Facts
- NPI
- 1184061699
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 2
- Locations
- 1
- Years in Practice
- 14
- Publications
- 20
Are you this provider?
Claim Your Profile